PIONEERING THE FUTURE Trademark

Trademark Overview

On Monday, June 2, 2014, a trademark application was filed for PIONEERING THE FUTURE with the United States Patent and Trademark Office. The USPTO has given the PIONEERING THE FUTURE trademark a serial number of 86297536. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 20, 2017. This trademark is owned by Novartis AG. The PIONEERING THE FUTURE trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of growth deficiency and autoimmune disorders; biological preparations for medical purposes and for the treatment of diseases in the fields of nephrology and oncology
pioneering the future

General Information

Serial Number86297536
Word MarkPIONEERING THE FUTURE
Filing DateMonday, June 2, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements

Goods and ServicesBiological preparations for the treatment of growth deficiency and autoimmune disorders; biological preparations for medical purposes and for the treatment of diseases in the fields of nephrology and oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 13, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, November 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2017EXTENSION 5 GRANTED
Saturday, April 8, 2017EXTENSION 5 FILED
Saturday, April 8, 2017TEAS EXTENSION RECEIVED
Wednesday, October 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2016EXTENSION 4 GRANTED
Thursday, October 13, 2016EXTENSION 4 FILED
Thursday, October 13, 2016TEAS EXTENSION RECEIVED
Friday, April 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 3 GRANTED
Monday, April 11, 2016EXTENSION 3 FILED
Monday, April 11, 2016TEAS EXTENSION RECEIVED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2015EXTENSION 2 GRANTED
Monday, October 12, 2015EXTENSION 2 FILED
Wednesday, October 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 12, 2015TEAS EXTENSION RECEIVED
Friday, April 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2015EXTENSION 1 GRANTED
Wednesday, April 8, 2015EXTENSION 1 FILED
Wednesday, April 8, 2015TEAS EXTENSION RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 10, 2014ASSIGNED TO EXAMINER
Friday, June 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 5, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

future pioneering biological treatment preparations diseases fields oncology purposes nephrology disorders growth